Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 11, 2000, Pages 912-919

  Bastien, M C ^a   Leblond, F ^a   Pichette, V ^a   Villeneuve, J P ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bile duct ligation; Breath test; Carbon tetrachloride; Cirrhosis; Cytochrome P450

Indexed keywords

AMINOPHENAZONE; CAFFEINE; CARBON TETRACHLORIDE; CYTOCHROME P450 1A; CYTOCHROME P450 2C; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; DIMETHYLNITROSAMINE; DIMETHYLNITROSAMINE DEMETHYLASE; ERYTHROMYCIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BREATH ANALYSIS; CATALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG ELIMINATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; IMMUNOBLOTTING; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER FUNCTION; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033695319     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y00-066     Document Type: Article

References (41)

1. Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6
2. Mephenytoin in disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis
3. 14C-nitosodimethylamine breath test
4. Drugs in liver diseases
5. Metabolism of antipyrine in vivo in two rat models of liver cirrhosis. Its relationship to intrinsic clearance in vitro and microsomal membrane lipid composition
6. Bile acids produce a generalized reduction of the catalytic activity of cytochrome P450 and other hepatic microsomal enzymes in vitro: Relevance to drug metabolism in experimental cholestasis
7. Comparison of four different carboxylterminal tracers in a radioimmunoassy specific to the 68-84 region of human parathyroid hormone
8. Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes
9. Clearance by the liver in cirrhosis. I: Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat
10. Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease
11. Chronic liver injury by thioacetamide and promotion of hepatic carcinogenesis
12. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxyde hydrolase in normal and disease states using immunochemical analysis of surgical liver samples
13. Hepatic microcirculation changes in a new model of biliary cirrhosis associating formalin injection and ligation of the bile ducts in the rat
14. Preparation of iodine-131 labelled human growth hormone of high specific activity
15. Mechanism of cholestasis. 1. Effect of bile acids on microsomal cytochrome P-450 dependent biotransformation system in vitro
16. Aminopyrine metabolism by multiple forms of cytochrome P450 from rat liver microsomes: Simultaneous quantitation of four aminopyrine metabolites by high performance liquid chromatography
17. Measurement of fibrosis in needle liver biopsies: Evaluation of a colorimetric method
18. Mechanism of induction of hepatic drug metabolizing enzymes by ethanol. I. Limited role of microsomal phospholipids
19. Differential regulation of liver P450 III cytochrome in choline-deficient rats: Implications for the erythromycin breath test as a parameter of liver function
20. Cleavage of strural proteins during the assembly of the head of bacteriophage T4
21. Expiratory measurements of maximal aminopyrine demethylation in vivo: Effect of phenobarbital, partial hepatectomy, portocaval shunt, and bile duct ligation in the rat
22. Quantitative liver function tests as surrogate markers for endpoints in controlled clinical trials: A retrospective feasibility study
23. The erythromycin breath test selectively measures P450 IIIA in patients with severe liver disease
24. Protein measurement with the Folin phenol reagent
25. 450 in the bile duct ligated rat
26. Enhanced hepatotoxicity of carbon tetrachloride, thioacetamide and dimethylnitrosamine by pretreatment of rats with ethanol and some comparisons with potentiation by isopropanol
27. The disposition of dapsone in cirrhosis
28. Drug metabolism in cirrhosis. Selective changes in cytochrome P-450 isozymes in the choline-deficient rat model
29. Impaired androgen 16α-hydroxylation in hepatic microsomes from carbon tetrachloride-cirrhotic male rats
30. Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model
31. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature
32. The aminopyrine breath test
33. Assessment of hepatic function with xenobiotics
34. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study
35. Caffeine: A model compound for measuring liver function
36. Differential effect of biliary and micronodular cirrhosis on oxidative drug metabolism. In vitro-in vivo correlations of dextromethorphan metabolism in rat models
37. Caffeine demethylation measured by breath test analysis in experimental liver injury in the rat
38. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
39. Assessement of liver function by the aminopyrine breath test
40. Erythromycine breath test as an assey of glucocoticoid-inducible liver cytochrome P-450. Studies in rats and patients
41. Unimpaired induction of drug-metabolizing enzymes in hepatocytes isolated from rats with micronodular cirrhosis